Excelsior Biopharma Inc.

NT$23.05As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6496Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (6.60%)
Div yield —
ROE (24.55%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.16)
PE TTM —
TSR TTM (20.24%)
Mkt cap NT$1.074B
ROIC (16.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$25
8.61%
(57.04%)
Hold 3|9|9|12|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.24
0.27
0.29
0.32
5.90%
16.90%
13.93%
25.19%
RevenueNT$M
70.64
69.43
70.09
72.49
2.91%
1.42%
0.18%
0.59%
Peers (US$32.43M)
Cap (US$)
PE
32.68M
—
Capital
TTM
5Y
10Y
Leveragex
0.647
0.033
0.031
EBIT/Intx
0.468
0.574
0.551
Own earn%
(89.03)
44.55
38.57
Sh yield%
28.93
64.52
63.91
Owners
Insiders/Inst%
10.99
69.45
Short interest%
3.88
SBC / revenue%
0.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
3–10
$1 testx
0.2
Incr. ROIC%
5